Literature DB >> 29693289

LncRNA ATB promotes proliferation and metastasis in A549 cells by down-regulation of microRNA-494.

Yiwei Cao1, Xiangjun Luo2, Xiaoqian Ding1, Shichao Cui1, Caihong Guo1.   

Abstract

Lung cancer is a commonly diagnosed disease with poor prognosis. Novel therapeutic targets and deep understanding of the regulatory mechanisms in lung cancer are of great importance. We aimed to figure out the functional roles of lncRNA-activated by transforming growth factor-β (ATB) in A549 cells as well as the underlying molecular mechanisms. ATB was non-physiologically expressed in A549 cells after cell transfection. Then, cell proliferation, expressions of proteins related to proliferation and epithelial-mesenchymal transition (EMT), migration, and invasion were measured by BrdU incorporation assay, Western blot analysis, and Transwell assay, respectively. Afterwards, miR-494 expression in transfected A549 cells was determined by quantitative reverse transcription PCR. Meanwhile, effects of miR-494 overexpression on ATB-overexpressed cells were assessed. Finally, the phosphorylation levels of AKT and key kinases in the Janus-activated kinase (JAK)/signal transducer and activator of transcription-3 (STAT3) pathway were detected by Western blot analysis. ATB overexpression promoted proliferation, migration, and invasion of A549 cells. Meanwhile, EMT of A549 cells was also enhanced. ATB silence showed the opposite influence. Expression of miR-494 was negatively regulated by ATB. Following experiments showed ATB-induced alterations of proliferation, migration, invasion, and EMT were all reversed by miR-494 overexpression. Finally, we proved that ATB increased phosphorylated levels of AKT, JAK1, and STAT3, and those increases were all reversed by miR-494 overexpression. We interestingly figured out that ATB promoted proliferation, migration, invasion, and EMT through down-regulating miR-494 in A549 cells. Moreover, ATB might activate AKT and the JAK/STAT3 pathway via down-regulating miR-494.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  AKT/JAK/STAT3; lncRNA ATB; lung cancer; microRNA-494; tumorigenesis

Mesh:

Substances:

Year:  2018        PMID: 29693289     DOI: 10.1002/jcb.26894

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  13 in total

1.  LINC01118 Modulates Paclitaxel Resistance of Epithelial Ovarian Cancer by Regulating miR-134/ABCC1.

Authors:  Cong Shi; Min Wang
Journal:  Med Sci Monit       Date:  2018-12-06

2.  lncRNA-ATB functions as a competing endogenous RNA to promote YAP1 by sponging miR-590-5p in malignant melanoma.

Authors:  Kuanhou Mou; Bo Liu; Meiling Ding; Xin Mu; Dan Han; Yan Zhou; Li-Juan Wang
Journal:  Int J Oncol       Date:  2018-06-25       Impact factor: 5.650

Review 3.  TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis.

Authors:  Yang Hao; David Baker; Peter Ten Dijke
Journal:  Int J Mol Sci       Date:  2019-06-05       Impact factor: 5.923

4.  Up-regulated LncRNA-ATB regulates the growth and metastasis of cholangiocarcinoma via miR-200c signals.

Authors:  Hai Lin; Lili Yang; Feng Tian; Shuang Nie; Hailang Zhou; Jun Liu; Weichang Chen
Journal:  Onco Targets Ther       Date:  2019-09-13       Impact factor: 4.147

5.  LncRNA-ATB Promotes Cisplatin Resistance in Lung Adenocarcinoma Cells by Targeting the miR-200a/β-Catenin Pathway.

Authors:  Weiwei Tang; Xiuyi Yu; Ru Zeng; Lilin Chen
Journal:  Cancer Manag Res       Date:  2020-03-18       Impact factor: 3.989

Review 6.  MicroRNAs as Theranostics Targets in Oral Carcinoma Stem Cells.

Authors:  Pei-Ling Hsieh; Yi-Wen Liao; Martin Pichler; Cheng-Chia Yu
Journal:  Cancers (Basel)       Date:  2020-02-03       Impact factor: 6.639

7.  Association between polymorphism in CDKN2B-AS1 gene and its interaction with smoking on the risk of lung cancer in a Chinese population.

Authors:  Xiaoting Lv; Zhigang Cui; Hang Li; Juan Li; Zitai Yang; Yanhong Bi; Min Gao; Ziwei Zhang; Shengli Wang; Baosen Zhou; Zhihua Yin
Journal:  Hum Genomics       Date:  2019-11-27       Impact factor: 4.639

8.  LINC00958 promotes the proliferation of TSCC via miR-211-5p/CENPK axis and activating the JAK/STAT3 signaling pathway.

Authors:  Bo Jia; Junfeng Dao; Jiusong Han; Zhijie Huang; Xiang Sun; Xianghuai Zheng; Shijian Xiang; Huixi Zhou; Shuguang Liu
Journal:  Cancer Cell Int       Date:  2021-03-03       Impact factor: 5.722

Review 9.  Long non-coding RNAs in lung cancer: implications for lineage plasticity-mediated TKI resistance.

Authors:  Tongyan Liu; Chencheng Han; Panqi Fang; Hongyu Zhu; Siwei Wang; Zhifei Ma; Quanli Zhang; Wenjia Xia; Jie Wang; Lin Xu; Rong Yin
Journal:  Cell Mol Life Sci       Date:  2020-11-10       Impact factor: 9.261

10.  The prognostic value of long noncoding RNA activated by TGF-β in digestive system cancers: A meta-analysis.

Authors:  Houyu Duan; Xiang Ding; Hesheng Luo
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.